GL1X · GenesisL1 explorer

MolNFT v1 · #114457 · protein

Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with bms-824171 aka 6-[(3R)-3-(4-tert-bu tylbenzamido) piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) PHENYL]AMINO}PYRIDINE- 3-carboxamide

5BQ0 · Tyrosine-protein kinase btk: “Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with bms-824171 aka…”. X-ray diffraction, 1 ligand (4US), 2 pockets (best druggability 0.70). MolNFT v1 #114457 on GenesisL1: 3D…

PDB
5BQ0
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
4US
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein26542% helix, 17% strandQ06187

Ligands and binding sites

  • 4US · 4-(2-chlorophenyl)-7-[(4-methylpiperazin-1-yl) carbonyl]-9H-carbazole-1-carboxamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14160.700.81594US, EDO
21000.360.7419EDO

Compared structures

  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.